Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia
Indian Journal of Ophthalmology · 2026
DOI: 10.4103/ijo.ijo_218_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2026. Verfasst von Nir Gomel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tel Aviv Sourasky Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Lenses, Intraocular, Visual Acuity, Iris, Lens Implantation, Intraocular. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
The Reper device (Reper-NN LTD, Nizhny Novgorod, Russia), an acrylic iris diaphragm combined with an intraocular lens (IOL), may be adapted for patients with various iris defects and aphakia. We aim to present our experience using the Reper artificial iris-IOL device.
Setting
Tertiary medical center.
Methods
This study includes patients who underwent implantation of the Reper artificial iris-IOL device at a single tertiary medical center between 2017 and 2023. The non-parametric signed test was used to compare preoperative and postoperative outcomes.
Results
Fifteen patients with aphakia and partial aniridia were included (four females [27%], mean age: 68.3). Mean follow-up time was 7.87 ± 5.62 months (range: 1–20). Following surgery, 87% (13 patients) showed improvement in corrected distance visual acuity (CDVA), while 13% (two patients) maintained their preoperative CDVA. The mean improvement in CDVA was 0.68 ± 0.19 logMAR ( P value = 0.0015 [95% confidence interval (CI): 0.28–1.08. Unpaired t -test]). Moreover, all patients (100%) expressed complete satisfaction with postoperative cosmetic outcomes.
Conclusion
This study represents the largest reported series on Reper artificial iris-IOL implantation procedure and provides initial insights into its outcomes. No surgical complications were reported, and most patients experienced VA improvement and cosmetic satisfaction. These findings may assist ophthalmic surgeons in evaluating the benefits and risks of this implant. Larger, longer-term studies are needed to better establish its safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Tel Aviv Sourasky Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Ophthalmology, Hadassah Medical Center, Jerusalem, Israel.
- Department of Ophthalmology, Rambam Health Care Campus Affiliated with the Technion-Israel Institute of Technology, Haifa, Israel.
Zitieren
APA
Gomel, N., Shemesh, N., Lavi, I., Achiron, A., Mimouni, M., Sorkin, N., Cohen, E., Verssano, D., & Levinger, E. (2026). Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_218_25
Vancouver
Gomel N, Shemesh N, Lavi I, Achiron A, Mimouni M, Sorkin N, et al. Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia. Indian Journal of Ophthalmology. 2026. doi:10.4103/ijo.ijo_218_25
BibTeX
@article{Gomel2026,
author = {Gomel, Nir and Shemesh, Nadav and Lavi, Itai and Achiron, Asaf and Mimouni, Michael and Sorkin, Nir and Cohen, Eyal and Verssano, David and Levinger, Eliya},
title = {Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia},
journal = {Indian Journal of Ophthalmology},
year = {2026},
doi = {10.4103/ijo.ijo_218_25}
}
EUVIMED